Rare Disease Research Center (희귀난치질환연구센터)
Results 1-20 of 100 (Search time: 0.006 seconds).
No. | Year | Title | Type |
---|---|---|---|
100 | 2023 | 2023Article Development of nucleocapsid-specific monoclonal antibodies for SARS-CoV-2 and their ELISA diagnostics on an automatic microfluidic deviceSensors and Actuators B-Chemical, vol. 380, pp. 133331-133331Jihyun Yang; V M Phan; Chang-Kyu Heo; H V Nguyen; Won-Hee Lim; Eun Wie Cho; Haryoung Poo; T S Seo |
Article |
99 | 2023 | 2023Research Project 국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 김두진 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
98 | 2022 | 2022Article Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide?conjugated BSAInternational Journal of Oncology, vol. 61, no. 6, pp. 158-158Chang-Kyu Heo; Won Hee Lim; Inseo Park; Y S Choi; K J Lim; Eun Wie Cho |
Article |
97 | 2022 | 2022Research Project 치료내성암 극복을 위한 인산화의존성 표적 TSPYL5 분해 유도 펩타이드 신약 연구 = Proteolysis-Inducing Phosphorylation Inhibitor Peptide Drug Development Targeting TSPYL5 for Combating Therapy-Resistance in연구책임자 : 조은위 / 사업기간 : 2022.08.01 ~ 2022.12.31 |
Research Project |
96 | 2022 | 2022Research Project mRNA Expresssion Cassette 개발연구책임자 : 김태돈 / 사업기간 : 2022.11.07 ~ 2023.11.06 |
Research Project |
95 | 2022 | 2022Research Project 국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 부하령 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
94 | 2022 | 2022Research Project 번역개시인자 eIF3A 매개 유전자 선택번역과 암발생에 관한 연구 및 eIF3A 적중 PROTAC 단백질분해 기술 기반 구축 = Oncogenic Translation triggered by Aberrant Expression of Translation Initiation Factor eIF3A and Development of the‘PROTAC’t연구책임자 : 조은위 / 사업기간 : 2022.03.01 ~ 2023.02.28 |
Research Project |
93 | 2021 | 2021Patent 엑소좀 단백질 EIF3A 특이반응 오토항체검출용 항원 조성물 및 이를 이용한 간암진단법CN201680052859.4 (2018.03.12) / ZL201680052859.4 (2021.11.02)고정헌; 황해민; 허창규; 조은위 |
Patent |
92 | 2021 | Patent | |
91 | 2021 | Patent | |
90 | 2021 | 2021Article Targeting therapy-resistant lung cancer stem cells via disruption of the AKT/TSPYL5/PTEN positive-feedback loopCommunications Biology, vol. 4, pp. 778-778I G Kim; J H Lee; S Y Kim; Chang-Kyu Heo; R K Kim; Eun Wie Cho |
Article |
89 | 2021 | 2021Research Project 국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 부하령 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
88 | 2021 | 2021Research Project 번역개시인자 eIF3A 매개 유전자 선택번역과 암발생에 관한 연구 및 eIF3A 적중 PROTAC 단백질분해 기술 기반 구축 = Oncogenic Translation triggered by Aberrant Expression of Translation Initiation Factor eIF3A and Development of the‘PROTAC’t연구책임자 : 조은위 / 사업기간 : 2021.03.01 ~ 2022.02.28 |
Research Project |
87 | 2020 | 2020Patent 엑소좀 단백질 EIF3A 특이반응 오토항체검출용 항원 조성물 및 이를 이용한 간암진단법US15/743,471 (2018.01.10) / 10,809,263 (2020.10.20)고정헌; 황해민; 허창규; 조은위 |
Patent |
86 | 2020 | 2020Article Cyclic peptide mimotopes for the detection of serum anti-ATIC autoantibody biomarker in hepato-cellular carcinomaInternational Journal of Molecular Sciences, vol. 21, no. 24, pp. 9718-9718Chang Kyu Heo; Hai Min Hwang; Won-Hee Lim; H J Lee; J S Yoo; K J Lim; Eun Wie Cho |
Article |
85 | 2020 | 2020Article HSPA1L enhances cancer stem cell-like properties by activating IGF1Rβ and regulating β-catenin transcriptionInternational Journal of Molecular Sciences, vol. 21, no. 18, pp. 6957-6957S I Choi; J H Lee; R K Kim; U Jung; Y J Kahm; Eun Wie Cho; I G Kim |
Article |
84 | 2020 | 2020Research Project 희귀 신경계질환 정밀·맞춤의학 원천 기술 개발 = Development of Genome-based Platform Technologies for Precision Medicine of Rare Neurological Diseases연구책임자 : 김남순 / 사업기간 : 2020.01.01 ~ 2020.12.31 |
Research Project |
83 | 2020 | 2020Research Project 국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 부하령 / 사업기간 : 2020.01.01 ~ 2020.12.31 |
Research Project |
82 | 2020 | 2020Research Project 번역개시인자 eIF3A 매개 유전자 선택번역과 암발생에 관한 연구 및 eIF3A 적중 PROTAC 단백질분해 기술 기반 구축 = Oncogenic Translation triggered by Aberrant Expression of Translation Initiation Factor eIF3A and Development of the‘PROTAC’t연구책임자 : 조은위 / 사업기간 : 2020.03.01 ~ 2021.02.28 |
Research Project |
81 | 2019 | 2019Article Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinomaScientific Reports, vol. 9, pp. 11059-11059Chang Kyu Heo; Hai Min Hwang; H J Lee; Sang-Seob Kwak; J S Yoo; Dae Yeul Yu; K J Lim; S Lee; Eun Wie Cho |
Article |